Stents (Bare-metal, Drug-eluting)
Clinical Outcomes After Long Lesion Stenting by Long Length Newer-generation Drug-eluting Stents in Real-world Patients
Sridhar Kasturi1, Shailender Singh1, Vijay Kumar Reddy Shanivaram2
Sunshine Hospital, India1, Sunshine hospital, India2
Multi-stenting for the long lesion is a common practice, which, however, leads to prolonged intracoronary modifications. Additionally, with an increase in the stent length, the risk of restenosis gets increased. Hence, the long lesion stenting is a challenge for coronary interventionists. The present all-comer, real-world registry was designed to evaluate the clinical outcomes after implantation of long length newer-generation drug-eluting stents(DES).
The current registry included coronary artery disease patients who underwent percutaneous coronary intervention for single or multi-vessel disease between May 2013 and March 2017. All the enrolled patients were implanted with at least one long (≥38mm) length DES. The primary clinical endpoint was the cumulative incidences of major adverse cardiac events(MACE) consisted of cardiac death, myocardial infarction(MI), and target lesion revascularization(TLR) at an 18-month follow up.
The newer-generation long length DES demonstrated a low MACE rate and favorable clinical outcomes when deployed in the high-risk long lesion real-world patients.